Combination of light and Ru (II) polypyridyl complexes: Recent advances in the development of new anticancer drugs

L Conti, E Macedi, C Giorgi, B Valtancoli… - Coordination Chemistry …, 2022 - Elsevier
The increasing impact of cancer on worldwide mortality makes the research of novel
chemotherapeutic agents a current and challenging issue. In the recent years, transition …

Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and …

HY Khan, A Ahmad, MN Hassan, YH Khan… - Coordination Chemistry …, 2024 - Elsevier
Metal ions play a key role in aggregation of amyloid β protein by interfering with their proper
folding, altering protein homeostasis and cell viability, and ultimately leading to …

Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease

S Shaikh, P Dhavan, G Pavale, MMV Ramana… - Bioorganic …, 2020 - Elsevier
A series of novel scaffold of N-substituted pyrazole derived α-aminophosphonates were
designed, synthesized and evaluated for their anti-cholinesterase activity. Porcine …

Inhibition of amyloid β1–42 peptide aggregation by newly designed cyclometallated palladium complexes

R Saini, GR Navale, S Singh, HK Singh… - International Journal of …, 2023 - Elsevier
Uncontrolled amyloid aggregation is a frequent cause of neurodegenerative disorders such
as prions and Alzheimer's disease (AD). As a result, many drug development approaches …

Importance of hydrogen bonding: structure–activity relationships of ruthenium (III) complexes with pyridine-based ligands for alzheimer's disease therapy

BJ Wall, MF Will, GK Yawson, PJ Bothwell… - Journal of medicinal …, 2021 - ACS Publications
Alzheimer's disease (AD) is the most common form of dementia, where one of the
pathological hallmarks of AD is extracellular protein deposits, the primary component of …

Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation

GR Navale, I Ahmed, MH Lim… - Advanced Healthcare …, 2024 - Wiley Online Library
Neurodegenerative disorders (NDDs) are a class of debilitating diseases that progressively
impair the protein structure and result in neurological dysfunction in the nervous system …

Design and synthesis of piano-stool ruthenium (II) complexes and their studies on the inhibition of amyloid β (1–42) peptide aggregation

S Singh, GR Navale, S Agrawal, HK Singh… - International journal of …, 2023 - Elsevier
Misfolding and protein aggregation have been linked to numerous human
neurodegenerative disorders such as Alzheimer's, prion, and Parkinson's diseases …

Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

S İrişli, S Günnaz, Ö Özcan, A Arı… - Applied …, 2024 - Wiley Online Library
For synthesizing metal–organic molecules with pro‐drug properties to prevent the
accumulation of amyloid beta (Aβ1–42), which is a feature of neurodegenerative Alzheimer's …

Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases

DL Ma, C Wu, G Li, TL Yung, CH Leung - Journal of Materials …, 2020 - pubs.rsc.org
Neurodegenerative diseases are the result of neurodegeneration, which is the process of
losing neuronal functions gradually due to the irreversible damage and death of neurons …

Peptide-based materials that exploit metal coordination

GA Bassan, S Marchesan - International Journal of Molecular Sciences, 2022 - mdpi.com
Metal–ion coordination has been widely exploited to control the supramolecular behavior of
a variety of building blocks into functional materials. In particular, peptides offer great …